These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 39013128)

  • 1. Opsoclonus-Ataxia Syndrome in a Patient With Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
    Farina A; Villagrán-García M; Benaiteau M; Lamblin F; Fourier A; Honnorat J; Joubert B
    Neurol Neuroimmunol Neuroinflamm; 2024 Sep; 11(5):e200287. PubMed ID: 39013128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraneoplastic Opsoclonus-myoclonus Syndrome with Anti-Hu and Anti-SOX-1 Antibodies after Immune-checkpoint Inhibitor Treatment Combined with Chemotherapy in a Patient with Small-cell Lung Cancer.
    Arai H; Utsu Y; Horio J; Furukawa S; Kikkawa Y
    Intern Med; 2022; 61(1):71-74. PubMed ID: 34980760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential fluctuating paraneoplastic ocular flutter-opsoclonus-myoclonus syndrome and Lambert-Eaton myasthenic syndrome in small-cell lung cancer.
    Simister RJ; Ng K; Lang B; Beckles M; Chao D; McCabe DJ
    J Neurol Neurosurg Psychiatry; 2011 Mar; 82(3):344-6. PubMed ID: 20392978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ipilimumab/Nivolumab-related Opsoclonus-Myoclonus-Ataxia Syndrome Variant in a Patient with Malignant Pleural Mesothelioma.
    Maller B; Peguero E; Tanvetyanon T
    J Immunother; 2018; 41(9):411-412. PubMed ID: 29742520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-SOX1 Antibody-positive Small-cell Lung Cancer That Triggered Opsoclonus.
    Chiko Y; Sugisaki Y; Miyoshi K; Morichika D; Beika Y; Taniguchi A; Ichihara E; Okada T
    Intern Med; 2023 Mar; 62(6):881-884. PubMed ID: 35989271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rare clinical presentation of COVID 19: opsoclonus-myoclonus ataxia syndrome.
    Altunsoy A; Kemirtlek N; Araz H; Dirik EB; Akıncı E
    J Infect Dev Ctries; 2024 Feb; 18(2):188-194. PubMed ID: 38484346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atezolizumab-induced cerebellar ataxia in a patient with metastatic small cell lung cancer: A case report and literature review.
    Kapagan T; Aksu F; Yuzkan S; Bulut N; Erdem GU
    J Oncol Pharm Pract; 2024 Jan; 30(1):201-205. PubMed ID: 37321205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment-refractory paraneoplastic opsoclonus-myoclonus syndrome in a patient with small-cell carcinoma of the lung.
    Alkan A; Cenikli U; Uylaş S; Yılmaz M; Çakır T; Çetinkaya H; Kıran A; Tanrıverdi Ö
    J Oncol Pharm Pract; 2020 Jan; 26(1):209-211. PubMed ID: 30791855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Small cell lung cancer complicated by opsoclonus myoclonus syndrome].
    Iwata T; Yokomura I; Ohsugi S; Uesaka A; Sekiguchi K; Nishio A
    Nihon Kokyuki Gakkai Zasshi; 2009 Nov; 47(11):1046-50. PubMed ID: 19994603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Dancing eyes, dancing feet syndrome' in small cell lung carcinoma.
    Sharma C; Acharya M; Kumawat BL; Kochar A
    BMJ Case Rep; 2014 Apr; 2014():. PubMed ID: 24759364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraneoplastic opsoclonus-myoclonus-ataxia syndrome revealing dual malignancy.
    Nasri A; Kacem I; Jerdak F; Djebara MB; Mejri N; Sidhom Y; Gargouri A; Gouider R
    Neurol Sci; 2016 Oct; 37(10):1723-5. PubMed ID: 27329274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer: a distinct paraneoplastic syndrome.
    Anderson NE; Budde-Steffen C; Rosenblum MK; Graus F; Ford D; Synek BJ; Posner JB
    Medicine (Baltimore); 1988 Mar; 67(2):100-9. PubMed ID: 3352511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF HIV RNA Escape in Opsoclonus-Myoclonus-Ataxia Syndrome: Case Report and Review of the Literature.
    Cabaraux P; Poncelet A; Honnorat J; Demeester R; Cherifi S; Manto M
    Front Neurol; 2020; 11():585527. PubMed ID: 33329331
    [No Abstract]   [Full Text] [Related]  

  • 14. Opsoclonus-myoclonus-ataxia syndrome associated with bacterial urinary tract infection.
    Jayasekara H; Wickramarathne JS; Liyanage DS; Jayasinghe PA
    BMJ Case Rep; 2024 Aug; 17(8):. PubMed ID: 39179267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postinfectious SARS-CoV-2 Opsoclonus-Myoclonus-Ataxia Syndrome.
    Nelson JL; Blume GM; Bansal SK; Kaufman JR; Woods FR; Zhang X; Kattah JC
    J Neuroophthalmol; 2022 Jun; 42(2):251-255. PubMed ID: 34974489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful use of tacrolimus for treatment-refractory neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome: A case series.
    Delap S; Shah N; Kuns O; Franklin B; Skeens MA
    Pediatr Blood Cancer; 2024 Apr; 71(4):e30903. PubMed ID: 38321586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opsoclonus-myoclonus syndrome associated with a nasopharyngeal tumor in an adult: a case report.
    Taib BG; Kinshuck AJ; Milburn-McNulty P; Fratalia L; Forsyth L; Husband D; Jones TM; Jacob A
    J Med Case Rep; 2015 Jun; 9():128. PubMed ID: 26033370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
    Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
    Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013257. PubMed ID: 33930176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and outcomes of opsoclonus myoclonus ataxia syndrome.
    Yıldırım M; Öncel İ; Bektaş Ö; Tanalı G; Şahin S; Kutluk T; Teber S; Anlar B
    Eur J Paediatr Neurol; 2022 Nov; 41():19-26. PubMed ID: 36155293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.